Orthopedics This Week recently examined Florida’s evolving framework for physician-directed stem cell therapies, including the responsibilities of physicians and biologics suppliers.
TAVRA Biosciences founder Priya Chordia was quoted in the article, emphasizing the importance of looking beyond whether a product is legally available to consider how it is sourced, manufactured, tested, documented, and delivered.
At TAVRA, we believe responsible access should be supported by consistent manufacturing, strong quality controls, lot-specific documentation, and clear information for physicians.